BSE filing, NSE: ANUHPHR. Summary written from the filing by ALFA Finder's alert engine.
Anuh Pharma Ltd: key numbers
- Share price
- ₹79.90
- Market cap
- ₹800.8 Cr
- Revenue (annual)
- ₹771.7 Cr
- Net profit (annual)
- ₹41.05 Cr
- P/E (TTM)
- 18.1×Sector 46.1×
- Promoter holding
- 71.80%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anuh Pharma Ltd
All →Anuh Pharma Acquisition Worth ₹72.9 Cr
Anuh Pharma signed an Asset Transfer Agreement to acquire a manufacturing facility from Vanquest Pharma for ₹72.90 Crore, increasing its production capacity by 525 MTPA.
- Value
- ₹72.90 Cr
- manufacturing capacity
- 525.0 MTPA
Anuh Pharma Debt & Borrowing: ₹75 Cr
Anuh Pharma Ltd board approved a loan of ₹75 Crore to finance manufacturing asset investments for expanding production capacity.
- Value
- ₹75.00 Cr
Anuh Pharma Other Announcement
Anuh Pharma Ltd filed the quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as issued by its RTA.
Anuh Pharma Legal & Regulatory
Anuh Pharma disclosed a Rs. 9,93,206 tax demand under Section 156, Income Tax Act, for AY 2018-19. The company plans to appeal before the CIT.
- Value
- ₹0.10 Cr
Anuh Pharma Investor Presentation: Key Takeaways
Anuh Pharma reported strong Q1 FY27 results with 4% YoY revenue growth and 38% PAT growth, driven by a shift to high-value regulated markets.
- Call
- Guides 18% growth
Anuh Pharma Management Change
Anuh Pharma announced the re-appointment of directors Arun Lalchand Todarwal and Bipin N. Shah, and the appointment of Ankit Kishor Chande as Cost Auditor.
Other board meeting date announcements
All →Trom Industries Board Meeting Date
TROM Industries Limited has scheduled a board meeting on 03-Nov-2026 to consider unaudited half-yearly standalone results for the period ended September 2026. The trading window closes from 01-Oct-2026 until 05-Nov-2026.
Archit Organosys Board Meeting Date
Archit Organosys will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window has been closed since October 1, 2026.
Ovobel Foods Board Meeting Date
Ovobel Foods will hold a board meeting on November 6, 2026 to consider unaudited results for the quarter ended September 2026. The trading window stays closed until 48 hours after the results announcement.
GNG Electronics Board Meeting Date
GNG Electronics will hold a board meeting on 3 November 2026 to consider unaudited half-year results. The trading window stays closed until 5 November 2026.
Arrowhead Seperation Engineering Board Meeting Date
Arrowhead Separation Engineering schedules a board meeting on November 3, 2026 to approve unaudited half-year results. The trading window stays closed until 48 hours after the meeting.
The Byke Hospitality Board Meeting Date
The Byke Hospitality will hold a board meeting on November 5, 2026 to approve unaudited quarterly and half-year results. Agenda items are only proposed at this stage.